Clincosm LogoSign in Get a demo

myelofibrosis

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthcare Resource Utilization in Adult Myelofibrosis Through

Recruiting
  • Myelofibrosis
    • La Plata, Buenos Aires, Argentina
    • +62 more
    Feb 1, 2023

    Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

    Recruiting
    • Myelofibrosis
    • Los Angeles, California
    • +41 more
    Jan 30, 2023

    Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +36 more
    Jan 13, 2023

    Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +13 more
    Jan 10, 2023

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Berkeley, California
    • +176 more
    Dec 1, 2022

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Anchorage, Alaska
    • +172 more
    Dec 1, 2022

    Myelofibrosis Trial in Worldwide (GB2064)

    Recruiting
    • Myelofibrosis
    • Houston, Texas
    • +11 more
    Nov 23, 2022

    Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

    Recruiting
    • Myelofibrosis
    • +5 more
    • Birmingham, Alabama
    • +27 more
    Oct 17, 2022

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +148 more
    Oct 10, 2022

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022

    Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +165 more
    Aug 19, 2022

    Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +36 more
    May 5, 2022

    Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

    Completed
    Has Results
    • Myelofibrosis
    • Imetelstat 4.7 mg/kg
    • Imetelstat 9.4 mg/kg
    • Birmingham, Alabama
    • +71 more
    Aug 17, 2021

    Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

    Completed
    • Polycythemia Vera
    • +2 more
    • JAK2V617F mutation
    • Olomouc, Czechia
    • +29 more
    Dec 5, 2019

    Erythroid Response in Myelodysplasia Undergoing Chelation

    Unknown status
    • Myelodysplasia
    • +2 more
      • Alessandria, AL, Italy
      • +19 more
      Jul 29, 2019

      Myelofibrosis Trial in Worldwide (INC424)

      Completed
      Has Results
      • Myelofibrosis
      • Alger, Algeria
      • +272 more
      Apr 25, 2019